Laboratory Guidelines for the Detection and Diagnosis of COVID-19 Virus Infection, 8 July 2020
Washington, D.C.; PAHO; 2020-07-08. (PAHO/IMS/PHE/COVID-19/20-0038).
Não convencional
em Inglês
| PAHO-IRIS
| ID: phr-52458
Biblioteca responsável:
US1.1
ABSTRACT
In January 2020, the etiologic agent responsible for a cluster of severe pneumonia cases in Wuhan, China, was identified as being a novel betacoronavirus, distinct from SARS-CoV and MERS-CoV. On 11 February 2020, the International Committee on Taxonomy of Viruses (ICTV) announced that the virus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). On the same day, WHO named the disease as coronavirus disease COVID-19. For communication purposes, we will refer the virus as “the virus responsible for COVID-19” or “the COVID-19 virus”. Complete genomic sequences of the COVID-19 virus have been released and different molecular detection protocols developed but not fully validated yet. However, given the current circulation of COVID-19 in the Americas region, the Pan American Health Organization/World Health Organization (PAHO/WHO) recommends to Member States to ensure timely identification of suspect cases, collection and shipment of samples to reference laboratories, and implementation of molecular detection protocols, according to the laboratory capacity.
Texto completo:
Disponível
Coleções:
Bases de dados de organismos internacionais
Contexto em Saúde:
ODS3 - Saúde e Bem-Estar
Problema de saúde:
Meta 3.8 Atingir a cobertura universal de saúde
Base de dados:
PAHO-IRIS
Assunto principal:
Coronavirus
/
COVID-19
/
Laboratórios
Tipo de estudo:
Estudo diagnóstico
/
Guia de prática clínica
Idioma:
Inglês
Ano de publicação:
2020
Tipo de documento:
Não convencional